跳至主要内容
临床试验/IRCT201203116934N2
IRCT201203116934N2已完成未知

The effect of combinant antioxidant supplementation on blood ADMA and VEGF levels and clinical outcomes in patient with rheumatoid arthritist

Pharmaceutical research center, Tabriz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
Female

入选标准

  • People with diagnosis of Rheumatoid arthritis disease according to American College of Rheumatology criteria (ACR) is confirmed. The doctor diagnosed according to criteria ACR (at least 4 criteria for six weeks : 1 - morning stiffness in the joint for at least an hour or more 2 - articular arthritis in three areas or more4: hand joint arthritis 5- symmetrical arthritis 5 - rheumatoid nodules 6 - positive rheumatoid factor 7 - typical radiographic changes in the wrist and hand) in adult patients with rheumatoid arthritis and patients visiting the doctor, at least for the past two months have not had a treatment change. Selected at random from among eligible women 30 -60 years old admitted with mild to moderate range of severity of illness would be a specialist; if DAS (Disease Activity Score) below 3/2 is a mild disease and the DAS (Disease Activity Score) is between 3/2-5/1, moderate severity is defined .

排除标准

  • 未提供

研究者

发起方
Pharmaceutical research center, Tabriz University of Medical Sciences

相似试验